As part of a plan to reduce its $32.5 billion debt burden, Teva Pharmaceuticals closed offices in New York City and Washington D.C., according to The Calcalist. According to Teva’s CEO Kåre ...

Meanwhile, manufacturing plants, R&D facilities and offices around the world will shut down or be sold. The cost-cutting plan comes courtesy of new CEO Kåre Schultz, whom Teva recently tapped to ...

NEW YORK--(BUSINESS WIRE)--The Law Offices of Vincent Wong announce that ... of Pennsylvania on behalf of investors who purchased Teva Pharmaceutical Industries Ltd. ("Teva") (NYSE: TEVA) American ...

In Ashdod, workers set tires on fire outside the Teva offices. The protests were held in parallel to a four-hour solidarity strike — the largest labor action to hit the country in several years ...

Drug giant Teva Pharmaceutical Industries Ltd. will move its headquarters from Petah Tikva to Ramat Hahayal in Tel Aviv, according to a report by Globes. “The expected move-in date will be mid-2 ...

Teva has agreed to pay a whopping $1.2 billion to settle a US lawsuit claiming its subsidiary Cephalon paid to hold up generic competition to its narcolepsy therapy Provigil.

Teva Pharmaceutical Industries Ltd. engages ... hospitals, and physician offices in the United States. The Europe segment offers OTC portfolio including SUDOCREM, NasenDuo, DICLOX FORTE, OLFEN ...

The Federal Trade Commission has opened an investigation into Teva Pharmaceuticals, citing the company’s refusal to take down about two dozen patents for its asthma and COPD inhalers ...